MedPath

Observational Study to Evaluate the occurrence of Age-Related Macular Degeneration (AMD) in Japanese Patients with genetic deficiency of Cholesteryl Ester Transfer Protein (CETP)

Not Applicable
Recruiting
Conditions
Patients with homozygous CETP deficiency
Registration Number
JPRN-jRCT1050230058
Lead Sponsor
Shiba Mariko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

1)Patients who give written consent by using a ICF approved by the Institutional Review Board or Independent Ethics Committee of the observational study site before starting procedures related to the observational study.
2)Male and female patients who are aged 50 years or older at the time of obtaining written consent
3)Patients with any of the following:
a)deficiency of cholesteryl ester transfer protein based on genetic test results
b)Patients with a CETP level of less than or equal to1.0 (microgram/milliliter) who may be diagnosed with a homozygous gene deficiency of cholesteryl ester transfer protein (CETP)

Exclusion Criteria

Patients who are unable to undergo ophthalmologic examination

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
occurence of AMD
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath